A Total exposure and risk assessment for drinking water contaminated with volatile organic compounds : final report /

"Printed: December 1987."

Cardiovascular Disease Prevention Task Force : preliminary report to the Illinois General Assembly, January 2000.

"Senate Joint Resolution 37."

Illinois Child Endangerment Risk Assessment Protocol /

Subtitle varies.

Risk assessment of exposure to radium and fluoride in Illinois public water supplies /

Prepared for Illinois Dept. of Energy and Natural Resources, Energy and Environmental Affairs Division.

The burden of cardiovascular disease and obesity in the state of Illinois : [a report to the governor of Illinois and the Illinois General Assembly as required by S.J.R. 37]

"P.O. #301078"--Colophon.

Superfund reassessment and reauthorization : hearings before the Subcommittee on Superfund, Waste Control, and Risk Assessment of the Committee on Environment and Public Works, United States Senate, One Hundred Fourth Congress, first session.

"April 27, and May 4, 9, and 11, 1995"--Pt. 2.

Annual report of the Division of Risk Assessment, National Center for Devices and Radiological Health /

Mode of access: Internet.

Shallow Landslide Risk Assessment of the Westerly Bluffs of the 7.5-minute Freeland Quadrangle, Whidbey Island, Washington

Landslides often occur on slopes rendered unstable by underlying geology, geomorphology, hydrology, weather-climate, slope modifications, or deforestation. Unfortunately, humans commonly exacerbate such unstable conditions through careless or imprudent development practices. Due to local geology, geography, and climatic conditions, Puget Sound of western Washington State is especially landslide-prone. Despite this known issue, detailed analyses of landslide risks for specific communities are few. This study aims to classify areas of high landslide risk on the westerly bluffs of the 7.5 minute Freeland quadrangle based on a combined approach: mapping using LiDAR imagery and the Landform Remote Identification Model (LRIM) to identify landslides, and implementation of the Shallow Slope Stability Model (SHALSTAB) to establish a landslide exceedance probability. The objective is to produce a risk assessment from two shallow landslide scenarios: (1) minimum bluff setback and runout and (2) maximum bluff setback and runout. A simple risk equation that takes into account the probability of hazard occurrence with physical and economic vulnerability (van Westen, 2004) was applied to both scenarios. Results indicate an possible total loss as much as $32.6b from shallow landslides, given a setback of 12 m and a runout of 235 m.

Emerging roles of urotensin-II in cardiovascular disease

Urotensin-II (UII) is a highly potent endogenous peptide within the cardiovascular system. Through stimulation of Galphaq-coupled UT receptors, UII mediates contraction of vascular smooth muscle and endothelial-dependent vasorelaxation, and positive inotropy in human right atrium and ventricle. A pathogenic role of the UT receptor system is emerging in cardiovascular disease states, with evidence for upregulation of the UT receptor system in patients with congestive heart failure (CHF), pulmonary hypertension, cirrhosis and portal hypertension, and chronic renal failure. In vitro and in vivo studies show that under pathophysiological conditions, UII might contribute to cardiomyocyte hypertrophy, extracellular matrix production, enhanced vasoconstriction, vascular smooth muscle cell hyperplasia, and endothelial cell hyper-permeability. Single nucleotide polymorphisms of the UII gene may also impart a genetic predisposition of patients to diabetes. Therefore, the UT receptor system is a potential therapeutic target in the treatment of cardiac, pulmonary, and renal diseases. UT receptor antagonists are currently being developed to prevent and/or reverse the effects of over-activated UT receptors by the endogenous ligand. This review describes UII peptide and converting enzymes, and UT receptors in the cardiovascular system, focusing on pathophysiological roles of UII in the heart and blood vessels. (C) 2004 Elsevier Inc. All rights reserved,

Cost-effectiveness analysis of a kidney and cardiovascular disease treatment program in an Australian aboriginal population

The objective of the study was to assess, from a health service perspective, whether a systematic program to modify kidney and cardiovascular disease reduced the costs of treating end-stage kidney failure. The participants in the study were 1,800 aboriginal adults with hypertension, diabetes with microalbuminuria or overt albuminuria, and overt albuminuria, living on two islands in the Northern Territory of Australia during 1995 to 2000. Perindopril was the primary treatment agent, and other medications were also used to control blood pressure. Control of glucose and lipid levels were attempted, and health education was offered. Evaluation of program resource use and costs for follow-up periods was done at 3 and 4.7 years. On an intention-to-treat basis, the number of dialysis starts and dialysis-years avoided were estimated by comparing the fate of the treatment group with that of historical control subjects, matched for disease severity, who were followed in the before the treatment program began. For the first three years, an estimated 11.6 person-years of dialysis were avoided, and over 4.7 years, 27.7 person-years of dialysis were avoided. The net cost of the program was $1,210 more per person per year than status quo care, and dialyses avoided gave net savings of $1.0 million at 3 years and $3.4 million at 4.6 years. The treatment program provided significant health benefit and impressive cost savings in dialysis avoided. (C) 2005 by the National Kidney Foundation, Inc.

Development and evaluation of the Clinician Suicide Risk Assessment Checklist

This paper describes the development and evaluation of a new instrument – the Clinician Suicide Risk Assessment Checklist (CSRAC). The instrument assesses the clinician’s competency in three areas: clinical interviewing, assessment of specific suicide risk factors, and formulating a management plan. A draft checklist was constructed by integrating information from 1) literature review 2) expert clinician focus group and 3) consultation with experts. It was utilised in a simulated clinical scenario with clinician trainees and a trained actor in order to test for inter-rater agreement. Agreement was calculated and the checklist was re-drafted with the aim of maximising agreement. A second phase of simulated clinical scenarios was then conducted and inter-rater agreement was calculated for the revised checklist. In the first phase of the study, 18 of 35 items had inadequate inter-rater agreement (60%>), while in the second phase, using the revised version, only 3 of 39 items failed to achieve adequate inter-rater agreement. Further evidence of reliability and validity are required. Continued development of the CSRAC will be necessary before it can be utilised to assess the effectiveness of risk assessment training programs.